Literature DB >> 9183306

Congestive heart failure in old age: prevalence, mechanisms and 4-year prognosis in the Helsinki Ageing Study.

M Kupari1, M Lindroos, A M Iivanainen, J Heikkilä, R Tilvis.   

Abstract

OBJECTIVE: To examine the prevalence, underlying diseases, abnormalities of left ventricular function and prognosis in congestive heart failure (CHF) of old age.
DESIGN: A population-based clinical and echocardiographic study with a 4-year mortality follow-up.
SETTING: University hospital.
SUBJECTS: Five hundred and one individuals born in 1904. 1909 and 1914 (367 women). MAIN OUTCOME MEASURES: Presence of CHF by clinical and chest radiograph criteria: left ventricular size and systolic function by echocardiography; grade of aortic and mitral valve lesion by Doppler echocardiography; 4-year total and cardiovascular mortality.
RESULTS: Forty-one of 501 participants (8.2%) had CHF. Ischaemic heart disease (54%), hypertension (54%) and moderate-to-severe mitral or aortic valve disease (51%) were the main underlying conditions; 90% of patients had one or more of these diseases. Most individuals with CHF (28 of 39 patients, 72%) had normal left ventricular contractions at echocardiography. 'Diastolic CHF', defined as CHF with normal systolic left ventricular function and no regurgitant valve disease, was found in 51% (20 of 39 patients). The relative 4-year risk for death associated with CHF, adjusted for age and sex, was 2.1 (95% confidence interval 1.3-3.4) for all-cause mortality and 4.2 (CI 1.9-5.6) for cardiovascular mortality.
CONCLUSIONS: The prevalence of CHF in a population aged 75-86 years is approximately 8%. Ischaemic or valvular heart disease and hypertension are the main underlying conditions. At echocardiography, about 50% of the elderly with CHF have normal left ventricular systolic contractions in the absence of valve disease and an additional 20% have normal systolic function with mitral regurgitation. The presence of CHF doubles the age- and sex-adjusted risk of death from all causes, and quadruples the risk of cardiovascular death during 4-year follow-up.

Entities:  

Mesh:

Year:  1997        PMID: 9183306     DOI: 10.1046/j.1365-2796.1997.129150000.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  38 in total

1.  Clinical pearls in cardiology.

Authors:  Stephen L Kopecky; Scott C Litin
Journal:  Mayo Clin Proc       Date:  2010-05       Impact factor: 7.616

2.  Echocardiographic features and brain natriuretic peptides in patients presenting with heart failure and preserved systolic function.

Authors:  M D Thomas; K F Fox; D A Wood; J S R Gibbs; A J S Coats; M Y Henein; P A Poole-Wilson; G C Sutton
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

Review 3.  Office management of patients with diastolic heart failure.

Authors:  Katina Tzanetos; Derek Leong; Robert C Wu
Journal:  CMAJ       Date:  2009-03-03       Impact factor: 8.262

4.  A qualitative study of the contribution of pharmacists to heart failure management in Scotland.

Authors:  Alexander M Clark; John J V McMurray; Caroline E Morrison; David L Murdoch; Simon Capewell; Margaret E Reid
Journal:  Pharm World Sci       Date:  2005-12

5.  Chronic heart failure in the elderly: value of cardiopulmonary exercise testing in risk stratification.

Authors:  L C Davies; D P Francis; M Piepoli; A C Scott; P Ponikowski; A J Coats
Journal:  Heart       Date:  2000-02       Impact factor: 5.994

Review 6.  Heart Failure With Preserved Ejection Fraction In Perspective.

Authors:  Marc A Pfeffer; Amil M Shah; Barry A Borlaug
Journal:  Circ Res       Date:  2019-05-24       Impact factor: 17.367

Review 7.  Epidemiology and clinical course of heart failure with preserved ejection fraction.

Authors:  Carolyn S P Lam; Erwan Donal; Elisabeth Kraigher-Krainer; Ramachandran S Vasan
Journal:  Eur J Heart Fail       Date:  2010-08-03       Impact factor: 15.534

8.  Nurse-based case management for aged patients with myocardial infarction: study protocol of a randomized controlled trial.

Authors:  Inge Kirchberger; Christa Meisinger; Hildegard Seidl; Rupert Wende; Bernhard Kuch; Rolf Holle
Journal:  BMC Geriatr       Date:  2010-05-27       Impact factor: 3.921

9.  Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial.

Authors:  Carolyn S P Lam; Peter E Carson; Inder S Anand; Thomas S Rector; Michael Kuskowski; Michel Komajda; Robert S McKelvie; John J McMurray; Michael R Zile; Barry M Massie; Dalane W Kitzman
Journal:  Circ Heart Fail       Date:  2012-08-10       Impact factor: 8.790

10.  The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study.

Authors:  David A Bluemke; Richard A Kronmal; João A C Lima; Kiang Liu; Jean Olson; Gregory L Burke; Aaron R Folsom
Journal:  J Am Coll Cardiol       Date:  2008-12-16       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.